Every SEC Form 3/4/5 on record for this filer (CIK 1559422) — 3 issuers, 97 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PUBLIC LTD CO | Chief Accounting Officer | 2015-08-14 → 2026-03-05 | 38 | −$10M |
| CYCC | Cyclacel Pharmaceuticals, Inc. | Director · lapsed | 2020-11-12 → 2023-07-03 | 5 | — |
| LSAC | LifeSci Acquisition Corp. | Director · lapsed | 2020-03-09 → 2020-03-09 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PRTA | 2024-01-24 | Sell | 5,000 | $34.00 | $170,000 | — |
| PRTA | 2023-12-20 | Sell | 3,322 | $37.45 | $124,409 | — |
| PRTA | 2023-12-20 | Sell | 1,678 | $36.68 | $61,549 | 3,322 |
| PRTA | 2023-11-30 | Sell | 5,000 | $34.00 | $170,000 | — |
| PRTA | 2023-10-25 | Sell | 2,917 | $41.38 | $120,705 | 294 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.
